BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37648653)

  • 1. Metformin has anti-inflammatory effects and induces immunometabolic reprogramming via multiple mechanisms in hidradenitis suppurativa.
    Petrasca A; Hambly R; Kearney N; Smith CM; Pender EK; Mac Mahon J; O'Rourke AM; Ismaiel M; Boland PA; Almeida JP; Kennedy C; Zaborowski A; Murphy S; Winter D; Kirby B; Fletcher JM
    Br J Dermatol; 2023 Nov; 189(6):730-740. PubMed ID: 37648653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the NLRP3 inflammasome reduces inflammation in hidradenitis suppurativa skin.
    Moran B; Smith CM; Zaborowski A; Ryan M; Karman J; Dunstan RW; Smith KM; Hambly R; Musilova J; Petrasca A; Fabre A; O'Donnell M; Hokamp K; Mills KHG; Housley WJ; Winter DC; Kirby B; Fletcher JM
    Br J Dermatol; 2023 Sep; 189(4):447-458. PubMed ID: 37243544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anti-inflammatory potency of biologics targeting tumour necrosis factor-α, interleukin (IL)-17A, IL-12/23 and CD20 in hidradenitis suppurativa: an ex vivo study.
    Vossen ARJV; Ardon CB; van der Zee HH; Lubberts E; Prens EP
    Br J Dermatol; 2019 Aug; 181(2):314-323. PubMed ID: 30657173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
    Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J
    Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin Treatment of Hidradenitis Suppurativa: Effect on Metabolic Parameters, Inflammation, Cardiovascular Risk Biomarkers, and Immune Mediators.
    Hambly R; Kearney N; Hughes R; Fletcher JM; Kirby B
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new T helper 17 cytokine in hidradenitis suppurativa: antimicrobial and proinflammatory role of interleukin-26.
    Scala E; Di Caprio R; Cacciapuoti S; Caiazzo G; Fusco A; Tortorella E; Fabbrocini G; Balato A
    Br J Dermatol; 2019 Nov; 181(5):1038-1045. PubMed ID: 30829398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix remodelling and MMP expression/activation are associated with hidradenitis suppurativa skin inflammation.
    Sanchez J; Le Jan S; Muller C; François C; Renard Y; Durlach A; Bernard P; Reguiai Z; Antonicelli F
    Exp Dermatol; 2019 May; 28(5):593-600. PubMed ID: 30903721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of hypoxia-inducible factor-1α in hidradenitis suppurativa: the link between deviated immunity and metabolism.
    Agamia NF; Sorror OA; Sayed NM; Ghazala RA; Echy SM; Moussa DH; Melnik BC
    Arch Dermatol Res; 2023 Sep; 315(7):2107-2118. PubMed ID: 36961533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulated cytokine expression in lesional and nonlesional skin in hidradenitis suppurativa.
    Kelly G; Hughes R; McGarry T; van den Born M; Adamzik K; Fitzgerald R; Lawlor C; Tobin AM; Sweeney CM; Kirby B
    Br J Dermatol; 2015 Dec; 173(6):1431-9. PubMed ID: 26282467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adalimumab (antitumour necrosis factor-α) treatment of hidradenitis suppurativa ameliorates skin inflammation: an in situ and ex vivo study.
    van der Zee HH; Laman JD; de Ruiter L; Dik WA; Prens EP
    Br J Dermatol; 2012 Feb; 166(2):298-305. PubMed ID: 22013960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation induced changes in the expression levels of components of the microRNA maturation machinery Drosha, Dicer, Drosha co-factor DGRC8 and Exportin-5 in inflammatory lesions of hidradenitis suppurativa patients.
    Hessam S; Sand M; Skrygan M; Gambichler T; Bechara FG
    J Dermatol Sci; 2016 Jun; 82(3):166-74. PubMed ID: 26917346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of anti-inflammatory effects of rifampicin in an ex vivo culture system of hidradenitis suppurativa.
    Haferland I; Wallenwein CM; Ickelsheimer T; Diehl S; Wacker MG; Schiffmann S; Buerger C; Kaufmann R; Koenig A; Pinter A
    Exp Dermatol; 2022 Jul; 31(7):1005-1013. PubMed ID: 35048417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The critical role of macrophages in the pathogenesis of hidradenitis suppurativa.
    Shah A; Alhusayen R; Amini-Nik S
    Inflamm Res; 2017 Nov; 66(11):931-945. PubMed ID: 28656364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin use in hidradenitis suppurativa.
    Jennings L; Hambly R; Hughes R; Moriarty B; Kirby B
    J Dermatolog Treat; 2020 May; 31(3):261-263. PubMed ID: 30893570
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety and Efficacy of Anakinra in Severe Hidradenitis Suppurativa: A Randomized Clinical Trial.
    Tzanetakou V; Kanni T; Giatrakou S; Katoulis A; Papadavid E; Netea MG; Dinarello CA; van der Meer JWM; Rigopoulos D; Giamarellos-Bourboulis EJ
    JAMA Dermatol; 2016 Jan; 152(1):52-59. PubMed ID: 26579854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenetic Characteristics of Mesenchymal Stem Cells in Hidradenitis Suppurativa.
    Campanati A; Orciani M; Sorgentoni G; Consales V; Offidani A; Di Primio R
    JAMA Dermatol; 2018 Oct; 154(10):1184-1190. PubMed ID: 30140888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tunnels in Hidradenitis Suppurativa: Active Inflammatory Entities with Specific Molecular and Genetic Profiles - A Narrative Review.
    Krajewski PK; Szepietowski JC; Martorell A
    Dermatology; 2023; 239(3):323-327. PubMed ID: 36822156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hidradenitis Suppurativa: Where We Are and Where We Are Going.
    Scala E; Cacciapuoti S; Garzorz-Stark N; Megna M; Marasca C; Seiringer P; Volz T; Eyerich K; Fabbrocini G
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Keratinocytes and immune cells in the epidermis are key drivers of inflammation in hidradenitis suppurativa providing a rationale for novel topical therapies.
    Schell SL; Cong Z; Sennett ML; Gettle SL; Longenecker AL; Goldberg SR; Kirby JS; Helm MF; Nelson AM
    Br J Dermatol; 2023 Feb; 188(3):407-419. PubMed ID: 36680309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hidradenitis Suppurativa: A Systematic Review Integrating Inflammatory Pathways Into a Cohesive Pathogenic Model.
    Vossen ARJV; van der Zee HH; Prens EP
    Front Immunol; 2018; 9():2965. PubMed ID: 30619323
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.